02/23/2026 | Press release | Distributed by Public on 02/23/2026 05:05
Financial Results
Atomera Incorporated (the "Company") incurred a net loss of ($4.4) million, or ($0.14) per basic and diluted share in the fourth quarter of 2025, compared to a net loss of ($5.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2025, and a net loss of ($4.7) million, or ($0.16) per basic and diluted share, for the fourth quarter of 2024. Adjusted EBITDA (a non-GAAP financial measure) in the fourth quarter of 2025 was a loss of ($3.3) million compared to an adjusted EBITDA loss of ($4.4) million in the third quarter of 2025 and ($3.9) million in the fourth quarter of 2024.
For fiscal year 2025, revenue was $65,000, compared with $135,000 in fiscal 2024. Net loss was ($20.2) million, or ($0.65) per basic and diluted share for fiscal 2025, compared to ($18.4) million, or ($0.68) per basic and diluted share in fiscal 2024. Adjusted EBITDA for fiscal 2025 was a loss of ($16.1) million compared to an adjusted EBITDA loss of ($15.4) million in fiscal 2024.
The Company had $19.2 million in cash, cash equivalents and short-term investments as of December 31, 2025, compared to $26.8 million as of December 31, 2024.
The total number of shares outstanding was 32.4 million as of December 31, 2025.
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
-- Financial Tables Follow --
| 1 |
Atomera Incorporated
Balance Sheets
(in thousands, except per share data)
| December 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 19,210 | $ | 25,778 | ||||
| Short-term investments | - | 995 | ||||||
| Accounts receivable | - | 6 | ||||||
| Interest receivable | 54 | 73 | ||||||
| Prepaid expenses and other current assets | 338 | 240 | ||||||
| Total current assets | 19,602 | 27,092 | ||||||
| Property and equipment, net | 60 | 59 | ||||||
| Long-term prepaid maintenance and supplies | - | 91 | ||||||
| Security deposit | 14 | 14 | ||||||
| Operating lease right-of-use asset | 884 | 280 | ||||||
| Financing lease right-of-use-asset | 533 | 1,588 | ||||||
| Total assets | $ | 21,093 | $ | 29,124 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 608 | $ | 492 | ||||
| Accrued expenses | 168 | 239 | ||||||
| Accrued payroll related expenses | 650 | 1,328 | ||||||
| Current operating lease liability | 147 | 260 | ||||||
| Current financing lease liability | 420 | 1,253 | ||||||
| Deferred revenue | 7 | 4 | ||||||
| Total current liabilities | 2,000 | 3,576 | ||||||
| Long-term operating lease liability | 712 | 22 | ||||||
| Long-term financing lease liability | - | 449 | ||||||
| Total liabilities | 2,712 | 4,047 | ||||||
| Commitments and contingencies | - | - | ||||||
| Stockholders' equity: | ||||||||
| Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding at December 31, 2025 and December 31, 2024 | - | - | ||||||
| Common stock: $0.001 par value, authorized 47,500 shares; 32,354 and 30,540 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively; | 32 | 31 | ||||||
| Additional paid-in capital | 260,043 | 246,565 | ||||||
| Other comprehensive income | - | 1 | ||||||
| Accumulated deficit | (241,694 | ) | (221,520 | ) | ||||
| Total stockholders' equity | 18,381 | 25,077 | ||||||
| Total liabilities and stockholders' equity | $ | 21,093 | $ | 29,124 | ||||
| 2 |
Atomera Incorporated
Statements of Operations
(in thousands, except per share data)
| Three Months Ended | Year Ended | |||||||||||||||||||
| December 31, | September 30, | December 31, | December 31, | |||||||||||||||||
| 2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||||||
| Revenue | $ | 50 | $ | 11 | $ | 23 | $ | 65 | $ | 135 | ||||||||||
| Cost of revenue | (131 | ) | (128 | ) | (13 | ) | (321 | ) | (123 | ) | ||||||||||
| Gross margin | (81 | ) | (117 | ) | 10 | (256 | ) | 12 | ||||||||||||
| Operating expenses | ||||||||||||||||||||
| Research and development | 2,740 | 3,304 | 2,823 | 12,303 | 11,029 | |||||||||||||||
| General and administrative | 1,505 | 2,165 | 1,811 | 7,806 | 7,266 | |||||||||||||||
| Selling and marketing | 286 | 207 | 248 | 758 | 1,053 | |||||||||||||||
| Total operating expenses | 4,531 | 5,676 | 4,882 | 20,867 | 19,348 | |||||||||||||||
| Loss from operations | (4,612 | ) | (5,793 | ) | (4,872 | ) | (21,123 | ) | (19,336 | ) | ||||||||||
| Other income (expense) | ||||||||||||||||||||
| Interest income | 195 | 232 | 213 | 931 | 779 | |||||||||||||||
| Accretion income | - | - | 26 | 6 | 178 | |||||||||||||||
| Other income, net | 1 | - | 1 | 72 | 73 | |||||||||||||||
| Interest expense | (9 | ) | (12 | ) | (25 | ) | (60 | ) | (129 | ) | ||||||||||
| Total other income (expense), net | 187 | 220 | 215 | 949 | 901 | |||||||||||||||
| Net loss | (4,425 | ) | $ | (5,573 | ) | (4,657 | ) | (20,174 | ) | (18,435 | ) | |||||||||
| Net loss per common share, basic and diluted | (0.14 | ) | $ | (0.17 | ) | (0.16 | ) | (0.65 | ) | (0.68 | ) | |||||||||
| Weighted average number of common shares outstanding, basic and diluted | 31,590 | 31,128 | 28,934 | 30,844 | 27,217 | |||||||||||||||
| 3 |
Atomera Incorporated
Reconciliation to Non-GAAP Adjusted EBITDA
(Unaudited)
| Three Months Ended | Year Ended | |||||||||||||||||||||||
| December 31, | September 30, | December 31, | December 31, | |||||||||||||||||||||
| 2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net loss (GAAP) | (4,425 | ) | $ | (5,573 | ) | (4,657 | ) | (20,174 | ) | (18,435 | ) | |||||||||||||
| Depreciation and amortization | 13 | 11 | 12 | 48 | 54 | |||||||||||||||||||
| Stock-based compensation | 1,334 | 1,342 | 949 | 4,963 | 3,867 | |||||||||||||||||||
| Interest income | (195 | ) | (232 | ) | (213 | ) | (931 | ) | (779 | ) | ||||||||||||||
| Accretion income | - | - | (26 | ) | (6 | ) | (178 | ) | ||||||||||||||||
| Other income, net | (1 | ) | - | (1 | ) | (72 | ) | (73 | ) | |||||||||||||||
| Interest expense | 9 | 12 | 25 | 60 | 129 | |||||||||||||||||||
| Net loss non-GAAP Adjusted EBITDA | (3,265 | ) | $ | (4,440 | ) | (3,911 | ) | (16,112 | ) | (15,415 | ) | |||||||||||||
| 4 |